Formoterol For Asthma: Evidence Of Serious Adverse Effects, Cochrane Researchers Review
10/17/2008 7:13:58 AM
ScienceDaily (Oct. 17, 2008) — Asthma sufferers who regularly take the beta2-agonist formoterol are more likely to suffer non-fatal serious adverse events than those given placebos. A review carried out by Cochrane Researchers showed a significantly increased risk for people who took the drug once or twice daily for at least 12 weeks.
comments powered by